China Steps Up Probe Into GlaxoSmithKline

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. John Dawson reports on Bloomberg Television's "Asia Edge." (Source: Bloomberg)

Crossbridge Capital CIO Says Oil Price Pop Is Likely
50:55 - Manish Singh, chief investment officer at Crossbridge Capital, discusses the factors he sees to support a rally in oil prices. He speaks on "Bloomberg Markets: European Open." (Source: Bloomberg)
  • What an Adjusted Border Tax Means for Businesses
  • JPMorgan's Bell Sees Opportunities in European Equities
  • China's WeChat Takes on the West